Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

AGNA ELIZABETH BAILEY

Allopathic & Osteopathic Physicians Family Medicine

NPI
1598762825
CMS profile
27145
Location
WILLOW PARK, TX

General Payments · PY2018–2024

$3,092.78

  • Reported across 197 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$440.33

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $440.33 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $202.14 2
Boehringer Ingelheim Pharmaceuticals, Inc. $54.10 2
Lilly USA, LLC $32.15 2
Biogen, Inc. $29.73 1
ABBVIE INC. $27.83 1
Novo Nordisk AS $22.04 1
GlaxoSmithKline, LLC. $17.10 1
Phathom Pharmaceuticals, Inc. $14.38 1
Amgen Inc. $13.95 1
PFIZER INC. $13.49 1
DEXCOM, INC. $13.42 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $450.38 32
PY2019 $732.94 60
PY2020 $1,072.05 68
PY2022 $21.78 1
PY2023 $375.30 22
PY2024 $440.33 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20182019202020222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $27.83 02/26/2024 Food and Beverage Undisputed 01/23/2026 1103264823 CMS
Amgen Inc. $13.95 04/19/2024 Food and Beverage Undisputed 01/23/2026 1117195549 CMS
AstraZeneca Pharmaceuticals LP $158.31 01/27/2024 Food and Beverage Undisputed 01/23/2026 1105644498 CMS
AstraZeneca Pharmaceuticals LP $43.83 09/17/2024 Food and Beverage Undisputed 01/23/2026 1104535947 CMS
Biogen, Inc. $29.73 09/06/2024 Food and Beverage Undisputed 01/23/2026 1104811353 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.73 02/28/2024 Food and Beverage Undisputed 01/23/2026 1118075063 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $32.37 06/10/2024 Food and Beverage Undisputed 01/23/2026 1118075065 CMS
Dexcom, Inc. $13.42 03/01/2024 Food and Beverage Undisputed 01/23/2026 1153276556 CMS
GlaxoSmithKline, LLC. $17.10 11/08/2024 Food and Beverage Undisputed 01/23/2026 1116437455 CMS
Lilly USA, LLC $16.36 09/30/2024 Food and Beverage Undisputed 01/23/2026 1136009339 CMS
Lilly USA, LLC $15.79 10/11/2024 Food and Beverage Undisputed 01/23/2026 1136008543 CMS
Novo Nordisk Inc $22.04 08/09/2024 Food and Beverage Undisputed 01/23/2026 1096573220 CMS
PFIZER INC. $13.49 05/13/2024 Food and Beverage Undisputed 01/23/2026 1131475545 CMS
Phathom Pharmaceuticals, Inc. $14.38 04/26/2024 Food and Beverage Undisputed 01/23/2026 1151037617 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.